应用复聪Ⅰ号治疗突发性耳聋患者200例,获得了比以往常用方法更为满意的效果。治愈率男性为57.1%,显效率为19.1%,好转率为7.9%,总有效率为84.1%。女性治愈率为71.6%,显效率为12.1%,好转率为4%,总有效率为87.7%。复聪Ⅰ号为复合性药物制剂,无毒副作用,治疗机理是扩张患者的内听动脉,增加血流量,解除内耳听觉感受器的血流性缺氧状态、抑制血中氧自由基的产生和清除自由基及其代谢物对内耳细胞的毒害作用,达到复聪的目的。 The application of Fucong I treatment of sudden deafness in 200 patients, obtained more than usual methods more satisfactory results. The cure rate was 57.1% in men, markedly effective rate was 19.1%, the improvement rate was 7.9%, the total effective rate was 84.1%. Female cure rate was 71.6%, markedly effective rate was 12.1%, improvement rate was 4%, the total effective rate was 87.7%. Fucong I No. composite drug agents, non-toxic side effects, treatment mechanism is to expand the patient’s internal auditory artery, increase blood flow, relieve the inner ear hearing aorexia blood flow hypoxia, inhibition of blood oxygen free radicals generation and elimination Free radicals and their metabolites on the toxic effects of the inner ear cells, to achieve the purpose of complex Cong.